Lantz Financial LLC Gilead Sciences, Inc. Transaction History

Lantz Financial LLC

$351 Million
Q3 2024

A detailed history of Lantz Financial LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Lantz Financial LLC holds 25,814 shares of GILD stock, worth $2.39 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

25,814

Previous 24,920 3.59%

Holding current value

$2.39 Million

Previous $1.71 Million 26.57%

% of portfolio

0.62%

Previous 0.55%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$66.59 - $83.99 $59,531 - $75,087	894 Added 3.59%	25,814 $2.16 Million
Q2 2024 Jul 10, 2024	BUY	$63.15 - $72.88 $53,046 - $61,219	840 Added 3.49%	24,920 $1.71 Million
Q1 2024 Apr 10, 2024	BUY	$71.58 - $87.29 $105,222 - $128,316	1,470 Added 6.5%	24,080 $1.76 Million
Q4 2023 Jan 12, 2024	BUY	$73.27 - $83.09 $51,655 - $58,578	705 Added 3.22%	22,610 $1.83 Million
Q3 2023 Oct 20, 2023	SELL	$73.94 - $80.67 $16,118 - $17,586	-218 Reduced 0.99%	21,905 $1.64 Million
Q2 2023 Jul 12, 2023	SELL	$76.01 - $86.7 $76,314 - $87,046	-1,004 Reduced 4.34%	22,123 $1.71 Million
Q1 2023 Apr 10, 2023	SELL	$77.31 - $88.08 $209,587 - $238,784	-2,711 Reduced 10.49%	23,127 $1.92 Million
Q4 2022 Jan 23, 2023	SELL	$62.32 - $89.47 $43,748 - $62,807	-702 Reduced 2.65%	25,838 $0
Q3 2022 Oct 17, 2022	BUY	$59.54 - $68.01 $13,098 - $14,962	220 Added 0.84%	26,540 $1.64 Million
Q2 2022 Jul 29, 2022	BUY	$57.72 - $65.01 $25,858 - $29,124	448 Added 1.73%	26,320 $1.63 Million
Q1 2022 May 05, 2022	BUY	$57.92 - $72.58 $139,529 - $174,845	2,409 Added 10.27%	25,872 $1.54 Million
Q4 2021 Jan 19, 2022	BUY	$64.88 - $73.64 $61,311 - $69,589	945 Added 4.2%	23,463 $1.7 Million
Q3 2021 Oct 14, 2021	BUY	$67.69 - $73.03 $36,484 - $39,363	539 Added 2.45%	22,518 $1.57 Million
Q2 2021 Jul 16, 2021	BUY	$63.47 - $69.35 $44,809 - $48,961	706 Added 3.32%	21,979 $1.51 Million
Q1 2021 Apr 19, 2021	BUY	$60.0 - $68.46 $46,200 - $52,714	770 Added 3.76%	21,273 $1.38 Million
Q4 2020 Jan 19, 2021	BUY	$56.65 - $64.55 $22,093 - $25,174	390 Added 1.94%	20,503 $1.2 Million
Q3 2020 Oct 09, 2020	BUY	$62.1 - $78.08 $52,536 - $66,055	846 Added 4.39%	20,113 $1.27 Million
Q2 2020 Jul 22, 2020	SELL	$72.34 - $84.0 $188,807 - $219,240	-2,610 Reduced 11.93%	19,267 $1.48 Million
Q1 2020 Apr 10, 2020	BUY	$62.63 - $80.22 $272,565 - $349,117	4,352 Added 24.83%	21,877 $1.64 Million
Q4 2019 Jan 17, 2020	SELL	$61.62 - $67.78 $204,578 - $225,029	-3,320 Reduced 15.93%	17,525 $1.14 Million
Q3 2019 Oct 18, 2019	BUY	$62.51 - $69.0 $68,448 - $75,555	1,095 Added 5.54%	20,845 $1.28 Million
Q2 2019 Jul 15, 2019	BUY	$61.87 - $69.38 $5,258 - $5,897	85 Added 0.43%	19,750 $1.36 Million
Q1 2019 Apr 22, 2019	BUY	$62.53 - $70.05 $1.23 Million - $1.38 Million	19,665 New	19,665 $1.28 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lantz Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lantz Financial LLC with notifications on news.

Account

Lantz Financial LLC Gilead Sciences, Inc. Transaction History